Hunter C. Smith - 16 Jun 2023 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Chief Financial Officer
Signature
/s/ Hunter C. Smith
Issuer symbol
RYTM
Transactions as of
16 Jun 2023
Net transactions value
+$13,760
Form type
4
Filing time
21 Jun 2023, 16:05:42 UTC
Previous filing
14 Feb 2023
Next filing
30 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise $13,760 +2,000 +3.4% $6.88 61,406 16 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Stock Option (right to buy) Options Exercise $0 -2,000 -1.2% $0.000000 161,094 16 Jun 2023 Common Stock 2,000 $6.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options are fully vested.